Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance

[1]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[2]  M. Lafontan,et al.  Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. , 2009, Biochemical and biophysical research communications.

[3]  H. Joost,et al.  Angiogenesis in the New Zealand obese mouse model fed with high fat diet , 2009, Lipids in Health and Disease.

[4]  G. McConell,et al.  POTENTIAL ROLE OF NITRIC OXIDE IN CONTRACTION‐STIMULATED GLUCOSE UPTAKE AND MITOCHONDRIAL BIOGENESIS IN SKELETAL MUSCLE , 2008, Clinical and experimental pharmacology & physiology.

[5]  Takuji Tanaka,et al.  Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice. , 2008, Carcinogenesis.

[6]  J. Cooke,et al.  Dimethylarginine Dimethylaminohydrolase Overexpression Enhances Insulin Sensitivity , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[7]  K. Miyashita,et al.  cGMP rescues mitochondrial dysfunction induced by glucose and insulin in myocytes. , 2008, Biochemical and biophysical research communications.

[8]  T. Kadowaki,et al.  The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS , 2008, FEBS letters.

[9]  T. Kadowaki,et al.  Adipogenesis in Obesity Requires Close Interplay Between Differentiating Adipocytes, Stromal Cells, and Blood Vessels , 2007, Diabetes.

[10]  M. Gannon,et al.  Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. , 2007, The American journal of pathology.

[11]  P. Vallance,et al.  The ADMA/DDAH pathway is a critical regulator of endothelial cell motility , 2007, Journal of Cell Science.

[12]  A. Navarro,et al.  The mitochondrial energy transduction system and the aging process. , 2007, American journal of physiology. Cell physiology.

[13]  L. Pénicaud,et al.  From heterogeneity to plasticity in adipose tissues: site-specific differences. , 2006, Experimental cell research.

[14]  Xin Xu,et al.  Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts. , 2005, American journal of physiology. Heart and circulatory physiology.

[15]  P. Tsao,et al.  Dimethylarginine Dimethylaminohydrolase Overexpression Suppresses Graft Coronary Artery Disease , 2005, Circulation.

[16]  S. Cinti.  The adipose organ. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[17]  Kunihiro Suzuki,et al.  Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. , 2005, Biochemical and biophysical research communications.

[18]  Y. Hattori,et al.  Hypoadiponectinemia is caused by chronic blockade of nitric oxide synthesis in rats. , 2005, Metabolism: clinical and experimental.

[19]  Wenjiang J. Fu,et al.  Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. , 2005, The Journal of nutrition.

[20]  H. Blau,et al.  Overexpression of Dimethylarginine Dimethylaminohydrolase Reduces Tissue Asymmetric Dimethylarginine Levels and Enhances Angiogenesis , 2005, Circulation.

[21]  E. Clementi,et al.  Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Russell,et al.  Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. , 2004, American journal of physiology. Endocrinology and metabolism.

[23]  A. Csiszar,et al.  Premature death and age-related cardiac dysfunction in male eNOS-knockout mice. , 2004, Journal of molecular and cellular cardiology.

[24]  D. Loskutoff,et al.  Angiogenesis in an in vivo model of adipose tissue development , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  H. Motoshima,et al.  Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. , 2004, Biochemical and biophysical research communications.

[26]  R. L. Richardson,et al.  Adipose tissue angiogenesis. , 2004, Journal of animal science.

[27]  P. Tsao,et al.  Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis: Genetic and Physiological Evidence , 2003, Circulation.

[28]  J. Cooke.  NO and angiogenesis. , 2003, Atherosclerosis. Supplements.

[29]  Y. Hattori,et al.  Globular adiponectin upregulates nitric oxide production in vascular endothelial cells , 2003, Diabetologia.

[30]  T. Ogihara,et al.  Association of Hypoadiponectinemia With Impaired Vasoreactivity , 2003, Hypertension.

[31]  Hui Chen,et al.  QUICKI is a useful index of insulin sensitivity in subjects with hypertension. , 2003, American journal of physiology. Endocrinology and metabolism.

[32]  J. Cooke.  Flow, NO, and atherogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Matsubara,et al.  Enhancement of Ischemia-Induced Angiogenesis by eNOS Overexpression , 2003, Hypertension.

[34]  U. Scherrer,et al.  Insulin resistance, a new target for nitric oxide‐delivery drugs , 2002, Fundamental & clinical pharmacology.

[35]  P. Tsao,et al.  Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase , 2002, Circulation.

[36]  J. Cooke,et al.  Nitric oxide and angiogenesis. , 2002, Circulation.

[37]  P. Vollenweider,et al.  Insulin Resistance, Hyperlipidemia, and Hypertension in Mice Lacking Endothelial Nitric Oxide Synthase , 2001, Circulation.

[38]  B. M. Rasmussen,et al.  Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study , 2001, Diabetologia.

[39]  Marina Ziche,et al.  Nitric Oxide and Angiogenesis , 2000, Journal of Neuro-Oncology.

[40]  E. Clementi,et al.  Oxidative stress and S‐nitrosylation of proteins in cells , 2000, British journal of pharmacology.

[41]  C. Sartori,et al.  Insulin, nitric oxide and the sympathetic nervous system: at the crossroads of metabolic and cardiovascular regulation. , 1999, Journal of hypertension.

[42]  P. Tsao,et al.  Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. , 1999, Circulation.

[43]  P. Arner,et al.  A nitric oxide‐mediated mechanism regulates lipolysis in human adipose tissue in vivo , 1999, British journal of pharmacology.

[44]  J. Pfeilschifter,et al.  Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. , 1997, The Journal of clinical investigation.

[45]  H. S. Kim,et al.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[47]  C. Garlanda,et al.  Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. , 1994, European journal of cell biology.

[48]  E. Kraegen,et al.  Influence of Dietary Fat Composition on Development of Insulin Resistance in Rats: Relationship to Muscle Triglyceride and ω-3 Fatty Acids in Muscle Phospholipid , 1991, Diabetes.

[49]  M. Kimoto,et al.  Metabolism of NG,NG-and NG,N'G-dimethylarginine in rats. , 1987, Archives of biochemistry and biophysics.

[50]  A. Aceto,et al.  The effect of pharmacological treatment on ADMA in patients with heart failure. , 2011, Frontiers in bioscience.

[51]  M. Haluzík,et al.  Adiponectin and its role in the obesity-induced insulin resistance and related complications. , 2004, Physiological research.

[52]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.

[53]  S. Gross,et al.  Nitric oxide: pathophysiological mechanisms. , 1995, Annual review of physiology.

[54]  A. Passaniti,et al.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[55]  Ming-Wei Lin,et al.  O R I G I N a L I N V E S T I G a T I O N Open Access the Association of Dimethylarginine Dimethylaminohydrolase 1 Gene Polymorphism with Type 2 Diabetes: a Cohort Study , 2022 .